MD Anderson to Acquire Bellicum’s Manufacturing Facility for $15M

 MD Anderson to Acquire Bellicum’s Manufacturing Facility for $15M

MD Anderson to Acquire Bellicum’s Manufacturing Facility for $15M

Shots:

  • MD Anderson signs an asset purchase agreement with Bellicum to acquire its 60,000-square-foot facility in Houston including its technical operation, quality staff, manufacturing, office and laboratory space for $15M. The transaction is expected to close in Q1’20
  • Additionally, the companies will sign a master services agreement, under which MD Anderson will operate Bellicum’s Houston facility and manufacture its GoCAR and other cellular therapy programs for clinical trials and early commercial supply
  • The supply agreement ensures Bellicum’s access to cell therapy product supply while reducing its operating expenses. MD Anderson will provide employment to ~35 employees at the Houston facility

Click here ­to­ read full press release/ article | Ref: Bellicum | Image: Houston Public media

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post